"10.1371_journal.pone.0127525","plos one","2015-06-15T00:00:00Z","Brandon S Nichols; Christine E Schindler; Jonathon Q Brown; Lee G Wilke; Christine S Mulvey; Marlee S Krieger; Jennifer Gallagher; Joseph Geradts; Rachel A Greenup; Jesko A Von Windheim; Nirmala Ramanujam","Department of Biomedical Engineering, Duke University, Durham, NC, United States of America; Department of Pathology, Duke University Medical Center, Durham, NC, United States of America; Department of Surgery, Duke University Medical Center, Durham, NC, United States of America; Department of Surgery, The University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America; Zenalux Biomedical, Research Triangle Park, NC, United States of America; Department of Biomedical Engineering, Tulane University, New Orleans, LA, United States of America; The Division of Environmental Sciences and Policy, Duke University, Durham, NC, United States of America","Conceived and designed the experiments: BSN NR JQB MSK J. Geradts RG. Performed the experiments: BSN CES CM J. Gallagher. Analyzed the data: BSN CES NR CM JQB J. Geradts. Contributed reagents/materials/analysis tools: BSN NR JVW JQB. Wrote the paper: BSN CES JQB LGW CM MSK J. Gallagher J. Geradts RG JVW NR.","Dr. Brown, Ms. Krieger, Dr. von Windheim, and Dr. Ramanujam own stock in, and have been employed by or provided consulting services for, Zenalux Biomedical, Inc., a company which developed portions of the technology described in this manuscript. Zenalux Biomedical has licenses, or options to license, intellectual property invented by Dr. Ramanujam and Dr. Brown. Zenalux Biomedical did not support any of the original work reported in this manuscript, either in cash or in kind. Zenalux, Inc. developed the 49-channel fiber-optic probe (trademark C49) and provided the imaging spectrograph described in this manuscript. All other components, including the light source, imaging platform, and acquisition software, were developed at Duke University. The Monte-Carlo inversion algorithm used as one component of the software is used under license to Zenalux, Inc., (US PATENT 7,570,988). This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2015","06","Brandon S Nichols","BSN",11,TRUE,5,4,6,7,TRUE,TRUE,TRUE,1,"9",FALSE
